TABLE 2.
Treatment |
14 days after inoculation |
||
Morbidity (%) | Disease index (%) | Control efficiency (%) | |
I-9 | 100 | 36.10 | 58.93a |
I-12 | 100 | 36.90 | 58.02a |
I-13 | 100 | 43.30 | 50.74c |
TS006 | 100 | 44.50 | 49.37b |
Bismerthiazol | 100 | 43.60 | 50.40c |
Thiodiazole copper | 100 | 46.70 | 46.87d |
CK | 100 | 87.90 | – |
The letters a–d denoted the results of difference significance analysis. The different letter indicates the values of activity with significant difference among different treatment groups (P < 0.05, Fisher’s LSD multiple comparison test).